Oren Livnat
Stock Analyst at H.C. Wainwright
Total Price Targets
9
Stocks Covered
7
Sectors
Healthcare
Most Recent
Nov 11, 2024
Stocks Covered by Oren Livnat
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | $6.60 | $6.87 | -3.9% | 1 | Nov 11, 2024 |
| TRVI | Trevi Therapeutics, Inc. | $6.00 | $15.25 | -60.7% | 1 | Oct 22, 2024 |
| ZVRA | Zevra Therapeutics, Inc. | $20.00 | $12.54 | +59.4% | 1 | Sep 23, 2024 |
| COLL | Collegium Pharmaceutical, Inc. | $50.00 | $34.27 | +45.9% | 2 | Sep 4, 2024 |
| PCRX | Pacira BioSciences, Inc. | $57.00 | $22.77 | +150.3% | 1 | Jul 2, 2024 |
| ANIP | ANI Pharmaceuticals, Inc. | $94.00 | $82.69 | +13.7% | 2 | Jun 26, 2024 |
| TARS | Tarsus Pharmaceuticals, Inc. | $61.00 | $60.52 | +0.8% | 1 | May 13, 2024 |
Recent Activity
- Nov 11, 2024— Set$6.60price target onXERS(Xeris Biopharma Holdings, Inc.)
- Oct 22, 2024— Set$6.00price target onTRVI(Trevi Therapeutics, Inc.)
- Sep 23, 2024— Set$20.00price target onZVRA(Zevra Therapeutics, Inc.)
- Sep 4, 2024— Set$50.00price target onCOLL(Collegium Pharmaceutical, Inc.)
- Jul 30, 2024— Set$47.00price target onCOLL(Collegium Pharmaceutical, Inc.)
- Jul 2, 2024— Set$57.00price target onPCRX(Pacira BioSciences, Inc.)
- Jun 26, 2024— Set$94.00price target onANIP(ANI Pharmaceuticals, Inc.)
- May 13, 2024— Set$61.00price target onTARS(Tarsus Pharmaceuticals, Inc.)
- May 13, 2024— Set$87.00price target onANIP(ANI Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Oren Livnat?
Oren Livnat is a stock analyst at H.C. Wainwright covering 7 stocks primarily in Healthcare. They have issued 9 price targets since May 13, 2024.
What stocks does Oren Livnat cover?
Oren Livnat currently covers 7 stocks, including COLL, ANIP, XERS, TRVI, ZVRA.
What is Oren Livnat's latest price target?
Oren Livnat's most recent price target was $6.60 on XERS (Xeris Biopharma Holdings, Inc.), set on Nov 11, 2024.
What is Oren Livnat's highest price target?
Oren Livnat's highest issued price target is $94.00 on ANIP, set on Jun 26, 2024.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.